Melphalan containing cytoreduction results in a good overall survival (OS) in pediatric patients with relapse or refractory AML undergoing unrelated umbilical cord blood transplantation (UCBT).
Prasad, VK; Wu, J; Martin, PL; Driscoll, TA; Parikh, SH; Semmel, D; Moffet, J; Stafford, L; Shonkwiler, A; Carter, S; Szabolcs, P; Kurtzberg, J
Volume / Issue
Start / End Page
International Standard Serial Number (ISSN)
48th Annual Meeting of the American-Society-of-Hematology
Conference Start Date
Conference End Date